What is the size of the Cancer Registry Software market in 2023?

The Cancer Registry Software market size is USD 78.6 Million in 2023.

What is the projected CAGR at which the Cancer Registry Software market is expected to grow at?

The Cancer Registry Software market is expected to grow at a CAGR of 10.1% (2024-2033).

List the segments encompassed in this report on the Cancer Registry Software market?

Market.US has segmented the Cancer Registry Software market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type the market has been segmented into Standalone Software and Integrated Software. By Deployment Model the market has been segmented into On-premise and Cloud-based. By Database the market has been segmented into Commercial Databases and Public Databases. By Functionality the market has been segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, and Medical Research & Clinical Studies. By End-user the market has been segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, and Research Centers.

List the key industry players of the Cancer Registry Software market?

Elekta, C/NET Solutions, Electronic Registry Systems Inc., Onco Inc., McKesson Corporation, Siemens Healthineers, IBM Corporation, Ordinal data, Inc., Conduent, Inc., Roche, and NeuralFrame, Inc.

Which region is more appealing for vendors employed in the Cancer Registry Software market?

North America is expected to account for the highest revenue share with 35.6%, and boasting an impressive market value of USD 27.9 Million. Therefore, the Cancer Registry Software industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Cancer Registry Software?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Cancer Registry Software Market.

Cancer Registry Software Market By Type (Standalone Software and Integrated Software), By Deployment Model (On-premise and Cloud-based), By Database (Commercial Databases and Public Databases), By Functionality (Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, and Medical Research & Clinical Studies), By End-user (Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, and Research Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Aug 2024
Report ID: 104207
Number of Pages: 211
Format:

- Elekta
- C/NET Solutions
- Electronic Registry Systems Inc.
- Onco Inc.
- McKesson Corporation
- Siemens Healthineers
- IBM Corporation
- Ordinal data, Inc.
- Conduent, Inc.
- Roche Holding AG Company Profile
- NeuralFrame, Inc

Related Reports

Our Clients

Report ID 104207
Published Date Aug 2024
Rating
- ★★★★★
  
  ★★★★★
- (30)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible